Amylyx Pharmaceuticals, Inc.
AMLX
$3.63
-$0.045-1.23%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -52.47% | -33.98% | -13.28% | 7.99% | 7.04% |
| Total Receivables | -98.65% | -94.12% | -87.77% | 17.64% | 156.55% |
| Inventory | -- | -- | -- | -- | 292.29% |
| Prepaid Expenses | -14.18% | -47.00% | 15.76% | 30.13% | 50.12% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -59.23% | -43.50% | -23.55% | 5.52% | 21.60% |
|
|
|||||
| Total Current Assets | -59.23% | -43.50% | -23.55% | 5.52% | 21.60% |
| Net Property, Plant & Equipment | -57.39% | -49.25% | -41.73% | -25.32% | -21.19% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -96.83% | -92.47% | -93.67% | -89.23% | 3,813.67% |
| Total Assets | -62.58% | -46.27% | -26.77% | 2.33% | 32.19% |
|
|
|||||
| Total Accounts Payable | -86.68% | -76.66% | -79.94% | 99.19% | 252.58% |
| Total Accrued Expenses | -58.51% | 36.20% | 68.52% | 75.15% | 50.67% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -32.74% | -10.40% | 10.39% | 10.46% | 10.64% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -65.38% | 18.19% | 9.36% | 77.54% | 76.02% |
|
|
|||||
| Total Current Liabilities | -65.38% | 18.19% | 9.36% | 77.54% | 76.02% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -76.62% | -76.82% | -75.42% | -62.59% | -53.27% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -65.64% | 13.13% | 5.40% | 68.18% | 65.25% |
|
|
|||||
| Common Stock & APIC | 4.52% | 5.01% | 5.70% | 6.09% | 6.23% |
| Retained Earnings | -98.95% | -83.79% | -50.18% | -20.16% | 13.91% |
| Treasury Stock & Other | -146.70% | 524.50% | -34.72% | -408.00% | 329.07% |
| Total Common Equity | -61.99% | -53.11% | -32.37% | -8.00% | 27.25% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -61.99% | -53.11% | -32.37% | -8.00% | 27.25% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -61.99% | -53.11% | -32.37% | -8.00% | 27.25% |
|
|
|||||
